Symphony Asset Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-14,795
Closed -$1.32M 309
2018
Q2
$1.32M Sell
14,795
-1,703
-10% -$141K 0.26% 84
2018
Q1
$1.47M Buy
16,498
+2,331
+16% +$224K 0.19% 129
2017
Q4
$1.48M Buy
14,167
+6,088
+75% +$687K 0.15% 150
2017
Q3
$1.18M Sell
8,079
-60
-0.7% -$8.17K 0.13% 162
2017
Q2
$1.06M Sell
8,139
-396
-5% -$48.5K 0.12% 178
2017
Q1
$1.06M Sell
8,535
-1,486
-15% -$178K 0.1% 202
2016
Q4
$1.16M Sell
10,021
-348
-3% -$38.8K 0.12% 181
2016
Q3
$1.08M Sell
10,369
-554
-5% -$60K 0.11% 185
2016
Q2
$1.08M Sell
10,923
-562
-5% -$58.1K 0.12% 173
2016
Q1
$1.15M Sell
11,485
-306
-3% -$31.5K 0.12% 175
2015
Q4
$1.41M Sell
11,791
-420
-3% -$48.6K 0.15% 152
2015
Q3
$1.32M Sell
12,211
-364
-3% -$45.2K 0.16% 148
2015
Q2
$1.46M Buy
12,575
+416
+3% +$47.6K 0.18% 140
2015
Q1
$1.4M Buy
12,159
+23
+0.2% +$2.75K 0.16% 135
2014
Q4
$1.36M Sell
12,136
-2,603
-18% -$275K 0.17% 138
2014
Q3
$1.4M Sell
14,739
-6,438
-30% -$581K 0.14% 142
2014
Q2
$1.82M Sell
21,177
-2,441
-10% -$186K 0.19% 138
2014
Q1
$1.65M Buy
23,618
+2,120
+10% +$168K 0.16% 160
2013
Q4
$1.82M Buy
21,498
+5,220
+32% +$413K 0.13% 148
2013
Q3
$1.25M Buy
16,278
+1,318
+9% +$92.4K 0.13% 153
2013
Q2
$875K Buy
+14,960
New +$900K 0.08% 222

Other funds holding CELG

Symphony Asset Management's CELG Position: Q3 2018 in Review

Symphony Asset Management sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 14,795 shares — an estimated $1.32M sold.

Symphony Asset Management first reported a position in CELG in Q2 2013 and held it in 21 quarters. The position peaked at $1.82M in Q2 2014. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Symphony Asset Management reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Symphony Asset Management sold 14,795 Celgene Corp shares in Q3 2018, an estimated $1.32M.
  • Symphony Asset Management first reported a position in Celgene Corp in Q2 2013 and held it in 21 quarters.
  • Symphony Asset Management's Celgene Corp position peaked at $1.82M in Q2 2014.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Symphony Asset Management's 13F filing for Q3 2018, filed 14 Nov 2018.